The supply problem reportedly affects materials needed to conduct blood tests and screening for diseases such as cancer.
Keystone / Alessandro Crinari
The Swiss pharmaceutical giant, one of the main suppliers of coronavirus diagnostic tests for Britain’s National Health Service (NHS), said a move to a new distribution warehouse last month was causing a delay in dispatching certain products.
The company has expressed regret over the situation and said it was prioritising the dispatch of Covid-19 diagnostic and antibody tests. However, it said it could take up to two weeks to resolve the issue.
The warehouse in East Sussex in Southern England is Roche’s only distribution centre in the UK, the BBC reportedExternal link.
According to one expert who spoke to the Reuters news agency, Roche is a major supplier of reagents used in routine blood tests, in cancer diagnostics and in Covid-19 tests.
More
More
Rapid Covid-19 tests could offer a path back to normal
This content was published on
Could rapid antigen tests like the one Roche plans to launch this month become the norm?
A spokesperson for Prime Minister Boris Johnson said on Wednesday the problem “is expected to have little to no impact on COVID testing,” Reuters reported. Earlier, Trade Minister Liz Truss had made similar reassurances.
But British media have reported that hospitals were already experiencing supply problems and feared rationing might be necessary. In a letter sent to NHS trusts, Roche advised the healthcare services to “prioritise essential services only.”
The delay in supply comes as the UK experiences a rise in new coronavirus infections and other recent glitches in its test-and-trace regime, including a technical problem that delayed the reporting of some 15,000 positive test results.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Roche in talks with Britain on Covid-19 antibody test
This content was published on
Britain is in talks with Swiss drugmaker Roche on rolling out an accurate Covid-19 antibody test that it said could be a game changer.
This content was published on
The Alpine nation is testing for coronavirus less than its European neighbours or the US, says a report by the Swiss public broadcaster.
Swiss group says machines can conduct 30m virus antibody tests
This content was published on
Swiss medical diagnostics company Quotient is poised to release machines that can conduct large scale coronavirus antibody tests.
United States regulator approves Roche’s Covid-19 antibody test
This content was published on
The US Food and Drug Administration (FDA) has given emergency approval for use of the serological test developed by the Swiss pharma giant.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.